Short Window For Senate, House To Agree On TEA Review Deadlines For FDA
This article was originally published in The Rose Sheet
Executive Summary
The Senate approves an amended version of the Sunscreen Innovation Act by unanimous consent, with a view toward speeding FDA reviews for all OTC ingredient TEAs. The House version addresses only sunscreen TEAs, and reconciliation of the two chambers’ bills likely will have to wait for the lame duck session.